Those rehired by the Trump administration include at least 10 FDA staffers responsible for reviewing the safety of new food ...
A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for ...
Patient advocacy groups had decried the firings, and lobbying groups rushed to save some slots that were in part funded by ...
A group that represents pharmacies that have been producing off-brand versions of GLP-1 weight-loss drugs just filed another ...
The FDA's new standards for foods before they can be labeled as "healthy" on their packaging will go into effect about two ...
Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment ...
Barely a week after mass firings at the Food and Drug Administration, some probationary staffers received unexpected news over the weekend: The government wants them back. Beginning Friday night, FDA ...
A nationwide recall of frozen nutritional shakes has been issued after a listeria outbreak tied to the drinks resulted in multiple hospitalizations and deaths across the United States, according to ...
The FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded ...
After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...
DOGE reportedly fired members of the FDA’s cardiac devices unit, which oversees devices like pacemakers and implantable defibrillators.
Hims & Hers stock tumbled after the company confirmed it would stop selling some compounded weight-loss drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results